| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2016-03-16 | GSK (UK) Miltenyi Biotec (Germany) | CAR-T cell-based oncology therapies | collaboration R&D |
Cancer - Oncology | R&D agreement | |
| 2016-03-16 | Acucela (USA - MA) YouHealth Eyetech, a subsidiary of Guangzhou Kang Rui Biological Pharmaceutical Technology (China) | lanosterol | Cataracts | Ophtalmological diseases | Licensing agreement | |
| 2016-03-16 | Kite Pharma (USA - CA) | nomination |
Nomination | |||
| 2016-03-16 | Cellectis (France) MabQuest (Switzerland) | monoclonal antibodies targeting PD-1 | R&D licensing |
Cancer - Oncology | R&D agreement | |
| 2016-03-16 | Valneva (France- Austria) U.S.Department of Defense (USA) | Ixiaro® | Japanese encephalitis | services contract |
Infectious diseases | Services contract |
| 2016-03-16 | Vedanta Biosciences (USA - MA) | nomination |
Autoimmune diseases – Inflammatory diseases - Infectious diseases | Nomination | ||
| 2016-03-16 | Vedanta Biosciences (USA - MA) | opening of new premises |
Autoimmune diseases – Inflammatory diseases - Infectious diseases | Opening of new premises | ||
| 2016-03-16 | Inovio Pharmaceuticals (USA - PA) The Wistar Institute (USA - PA) | preventive and therapeutic DNA-based immunotherapy applications and products for cancers and infectious diseases | R&D collaboration |
Cancer - Oncology - Infectious diseases | R&D agreement | |
| 2016-03-15 | Oncurious (Belgium) BioInvent (Sweden) Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) (USA-MI) | TB-403 | neuroblastoma, medulloblastoma and other pediatric cancers | clinical research |
Cancer - Oncology | Clinical research agreement |
| 2016-03-15 | Txcell (France) PCT, a Caladrius Company (USA - CA) | services contrat manufacturing production |
Technology - Services | Services contract | ||
| 2016-03-11 | OncoQR ML (Austria) TYG Oncology (UK) | therapeutic vaccines | gastrointestinal cancers | collaboration R&D |
Cancer - Oncology | Collaboration agreement |
| 2016-03-11 | Selvita (Poland) | establishment of a new subsidiary in the US |
Establishment of a new subsidiary in the US | |||
| 2016-03-11 | Inovio Pharmaceuticals (USA - PA) | nomination |
Cancer - Oncology - Infectious diseases | Nomination | ||
| 2016-03-10 | Evotec (Germany) Padlock Therapeutics (USA - MA) | inhibitors of protein-arginine deiminases (PADs) | collaboration |
Autoimmune diseases | Milestone | |
| 2016-03-10 | Gedeon Richter (Hungary) | biotechnology plant to develop and manufacture biosimilar products | construction of a production plant |
Technology - Services | Construction of a production plant | |
| 2016-03-09 | Immunovia (Sweden) Ehlers, Ehlers and Partner (Germany) | IMMray™ PanCan-d (blood based test for early detection of pancreatic cancer) | pancreatic cancer | collaboration |
Cancer - Oncology - Diagnostic | Collaboration agreement |
| 2016-03-09 | MDxHealth (Belgium) | nomination |
Cancer - Oncology - Rare diseases | Nomination | ||
| 2016-03-08 | Ipsen (France) Peptimimesis (France) | novel therapeutic peptides | R&D licensing commercialisation |
Cancer - Oncology | R&D agreement | |
| 2016-03-08 | Sarepta Therapeutics (USA - MA) | restructuring |
Rare diseases - Genetic diseases - Neuromuscular diseases | Restructuring | ||
| 2016-03-08 | Kuros Biosciences (Switzerland) | nomination |
Regenerative Medicine | Nomination |
